Tag Archives: Informed Consent

Psychiatric Drugs, School Violence, and Big Pharma Cover-Up

A study published June 12, 2018 from the University of Illinois at Chicago suggests that more than one-third (37.2%) of U.S. adults may be using prescription drugs that have the potential to cause depression or increase the risk of suicide. … Continue reading

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , , , , , | Leave a comment

Cannabidiol (CBD) – Can We Be Sure It’s Safe?

Every time we say “CBD” out loud we think Bidi Bidi and picture Buck Rogers’ Twiki the Robot. But really, what is CBD, and is it harmful or helpful? Derived from Cannabis (marijuana), CBD is one of many cannabinoids which … Continue reading

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , | Leave a comment

The Manufactured Crisis of Prescription Drug Prices

“Manufactured Crisis – How Devastating Drug Price Increases Are Harming America’s Seniors” This report was prepared in 2018 by the U.S. Senate Homeland Security & Governmental Affairs Committee Minority Office as requested by Senator Claire McCaskill of Missouri. It examines … Continue reading

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , | Leave a comment

Many People Taking Antidepressants Discover They Cannot Quit

The New York Times had an article April 7, 2018 discussing the fact that antidepressants are actually addictive and have withdrawal symptoms. Quotes are from this article. “As far back as the mid-1990s, leading psychiatrists recognized withdrawal as a potential … Continue reading

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , | Leave a comment

The Skinny on the Skin Drug

We saw a TV commercial recently for the drug Otezla® (generic apremilast), from Celgene Corporation, which was approved by the FDA in 2014 for the treatment of symptoms of moderate to severe plaque psoriasis (skin lesions) and psoriatic arthritis. Our … Continue reading

Posted in Big Muddy River Newsletter, Press Releases | Tagged , | Leave a comment

Knocked Out, Paralyzed, and Shocked

Electroconvulsive Therapy (ECT), or shock therapy, is a controversial psychiatric “treatment” in which seizures are deliberately induced in the patient with an electrical current to the brain. There are roughly 100,000 ECT sessions given per year in the U.S. The … Continue reading

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , | Leave a comment

Off-Label Drug Use May Be Risky

The February 2017 issue of Consumer Reports article, “Should Drugs Do Double Duty” says, “Your doctor might give you a drug for a condition that it’s not approved to treat. That’s a risk you may not want to take.” “Doctors … Continue reading

Posted in Big Muddy River Newsletter, Press Releases | Tagged , | Leave a comment

More About Marijuana and PTSD

More About Marijuana and PTSD  Recent news is full of articles about making marijuana legally available for those diagnosed with Post-Traumatic Stress Disorder (PTSD). While marijuana’s popularity may be based on the perception that it is safer than other methods … Continue reading

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , | Leave a comment

Risky Business of Sleep Drugs

Risky Business of Sleep Drugs After reading about the dangers of sleeping pills in the February 2016 edition of Consumer Reports magazine, we thought you might like to know something about that. Some psychotropic drugs are prescribed as sleeping pills. Trazodone, … Continue reading

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , , , , , | Leave a comment

Another Day Another Anti-depressant (Again)

Another Day Another Anti-depressant (Again) On July 10, 2015, the U.S. Food and Drug Administration approved Rexulti (brexpiprazole, an atypical antipsychotic) tablets to treat adults with so-called schizophrenia and as an add-on treatment to an antidepressant medication to treat adults with … Continue reading

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , , , | Leave a comment